BG Medicine BGMD soared 11.54% to $3.77 in the pre-market trading. BG Medicine obtained a CE Mark enabling the commercial sale of the CardioSCORE(TM) test in the EU.
Sucampo Pharmaceuticals SCMP moved up 10.66% to $5.50 in the pre-market session. Sucampo Pharma received approval of an sNDA for RESCULA (unoprostone isopropyl ophthalmic solution) from the FDA.
Clearwire CLWR added 5.60% to $2.83 in the pre-market session. Sprint Nextel S is in talks to buy the 49% of Clearwire, according to people familiar with the matter.
Oncothyreon ONTY surged 4.58% to $4.80 in the pre-market session. Oncothyreon's trailing-twelve-month ROE is -33.87%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in